Ask AI

Novel Approaches in Relapsed/Refractory Multiple Myeloma: Expert Perspectives on Emerging Data and Ongoing Trials

Boost your understanding of novel protein degraders for patients with multiple myeloma with this educational program featuring an on-demand webcast, downloadable slides, podcast, and ClinicalThought.

Share

Program Content

Activities

Novel Protein Degraders in MM
Novel Approaches in Multiple Myeloma: Expert Perspectives on Emerging Data and Ongoing Trials
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 10, 2026

Activities

Novel Approaches in RRMM
Novel Approaches in Relapsed/Refractory Multiple Myeloma: Expert Perspectives on Emerging Data and Ongoing Trials
Video
Congratulations: You achieved a completion on 04/09/2022

Released: July 13, 2026

Expires: January 12, 2027

Activities

FAQs on CELMoD Agents for MM
Experts Discuss HCP Questions on CELMoD Agent Therapy for Multiple Myeloma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 21, 2026

Activities

CELMoD Agents in MM
Experts Discuss CELMoD Agents for Multiple Myeloma
Podcast
Congratulations: You achieved a completion on 04/09/2022

Released: August 20, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

This activity is supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb